Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform

70% of circulating and splenic T cells positive for mRNA expression in humanized mice with less than 8% delivery to off-target immune cells Stealth properties of cell-targeted lipid nanoparticle ...

Related Keywords

Brussels ,Bruxelles Capitale ,Belgium ,Cambridge ,Cambridgeshire ,United Kingdom ,Matt Stanton ,Maren Killackey ,Phillip Samayoa ,Nasdaq ,Generation Bio Co ,European Society For Gene ,Moderna Inc ,Globenewswire Inc ,Exchange Commission ,Generation Bio ,Private Securities Litigation Reform Act ,Media Contact ,Markets ,